Twitter/X

On 2026-06-26 @FoundationOAI (OpenAI Foundation) announced it is joining…

Brief

The OpenAI Foundation announced on 26 June 2026 that it is joining Intercept as a founding partner through its AI resilience program to support Intercept Health Fund, a $500 million, pathogen‑agnostic initiative aimed at ending respiratory infections (including colds and flu) by investing in broad‑spectrum preventatives and non‑pharmaceutical interventions to guard against engineered outbreaks.

Why it matters

On 2026-06-26 @FoundationOAI (OpenAI Foundation) announced it is joining Intercept as a founding partner through its AI resilience program.

Key details

  • Intercept Health Fund is a $500M, pathogen-agnostic initiative that aims to end respiratory infections (including colds and flu) by investing in broad-spectrum preventatives and non-pharmaceutical interventions.
  • The Foundation framed the partnership as preparing for AI-accelerated risks in biology and medicine, including the potential for engineered outbreaks.
Source evidence

The OpenAI Foundation is joining Intercept as a founding partner through our AI resilience program.

As AI accelerates advances in biology and medicine, we also need to prepare for the risks of misuse, including the potential for engineered outbreaks.

Intercept Health Fund is working to end respiratory pandemics through a pathogen-agnostic approach, investing in broad-spectrum preventatives and non-pharmaceutical interventions that can protect against a wide range of threats and strengthen a new layer of resilience for humanity.

blog.interceptfund.com/p/end…

Link

Ending respiratory infections

Introducing Intercept, a $500M bet to make respiratory infections like colds and flu a thing of the past.
blog.interceptfund.com